Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 8, 2003, Pages 1475-1478

  Kim, Young Woo ^a   Mobley, James A ^b   Brueggemeier, Robert W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPYRAN DERIVATIVE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; OXYGEN; RALOXIFENE; SULFUR;

ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG DESIGN; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HORMONE RECEPTOR INTERACTION; STRUCTURE ACTIVITY RELATION;

EID: 0037451845     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00132-X     Document Type: Article

References (40)

1. (a) Bhat A.S., Whetstone J.L., Brueggemeier R.W. Tetrahedron Lett. 40:1999;2469
2. (b) Brueggemeier R.W., Richards J.A., Joomprabutra S., Bhat A.S., Whetstone J.L. J. Steroid Biochem. Mol. Biol. 79:2001;75
3. (c) Kim Y.-W., Brueggemeier R.W. Tetrahedron Lett. 43:2002;6113.
4. (a) Cassady J.M., Zennie T.M., Chae Y.H., Ferin M.A., Portuondo N.E., Baird W.M. Cancer Res. 48:1988;6257
5. (b) Vrijsen R., Everaert L., Boeye A. J. Gen. Virol. 69:1988;1749
6. (c) Dickancaite E., Nemeikaite A., Kalvelyte A., Cenas N. Biochem. Mol. Biol. Int. 45:1998;923.
7. (a) Jordan, V. C.; Koch, R.; Bain, R. R. In Estrogens in the Environment II: Influences on Development. McLachlan, J. A. Ed. Elsevier: New York, 1985, pp 221-234.
8. (b) Shun D.A., Cox R.I. J. Endocrinol. 52:1972;299
9. (c) Martin P.M., Horwitz K.B., Ruyan D.S., McGuire W.L. Endocrinology. 103:1978;1860.
10. So F.V., Guthrie N., Chambers A.F., Carroll K.K. Cancer Lett. 112:1997;127.
11. (a) Kellis J.T., Vickery L.E. Science. 225:1984;1032
12. (b) Wang C., Makela T., Hase T., Adlercreutz H., Kurzer M. S. J. Steroid Biochem. Mol. Biol. 50:1994;205
13. Kao Y.-C., Zhou C., Sherman M., Laughton C.A., Chen S. Environ. Health Perspect. 106:1998;85.
14. Wang T.T.Y., Sathyamoorthy N., Phang J. Carcinogenesis. 17:1996;271.
15. (a) Kuiper G.G.J.M., Carlsson B., Grandien J., Enmark E., Haggblad J., Nilsson S., Gustafsson J.Å. Endocrinology. 138:1997;863
16. (b) Pike A.C.W., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.-G., Engström O., Ljunggren J., Gustafsson J. Å., Carlquist M. EMBO J. 18:1999;4608
17. (c) Witkowska H.E., Carlquist M., Engstrom O., Carlsson B., Bonn T., Gustasson J., Shackleton C.H.L. Steroids. 27:1997;31.
18. (a) Clark J.W., Santos-Moore A., Stevenson L.E., Frackelton A.R. Jr. Int. J. Cancer. 65:1996;186
19. (b) Peterson G., Barnes S. Cell Growth Differ. 7:1996;1345.
20. Grese T.A., Dodge J.A. Curr. Pharm. Des. 4:1998;71.
21. (a) Grese T.A., Adrian M.D., Phillips D.L., Shetler P.K., Short L.L., Glasebrook A.L., Bryant H.U. J. Med. Chem. 44:2001;2857
22. (b) Stauffer S.R., Huang Y.R., Aron Z.D., Coletta C.J., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Bioorg. Med. Chem. 9:2001;151
23. (c) Mortensen D.S., Rodriguez, Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Bioorg. Med. Chem. Lett. 11:2001;2521
24. (d) Labrie F., Labrie C., Bélanger A., Simard J., Gauthier S., Luu-The V., Mérand Y., Giguere V., Candas B., Luo S., Martel C., Singh S.M., Fournier M., Coquet A., Richard V., Charbonneau R., Charpenet G., Tremblay A., Tremblay G., Cusan L., Veilleux R. J. Steroid Biochem. Mol. Biol. 69:1999;51
25. (e) Miller C., Collini M.D., Tran B.D., Harris H.A., Kharode Y.P., Marzolf J.T., Moran R.A., Henderson R.A., Bender R.H.W., Unwalla R.J., Greenberger L.M., Yardley J.P., Abou-Gharbia M.A., Lyttle C.R., Komm B.S. J. Med. Chem. 44:2001;1654
26. (f) Rosati R.L., Jardine P.D.S., Cameron K.O., Thompson D.D., Ke H.Z., Toler S.M., Brown T.A., Pan L.C., Ebbinghaus C.F., Reinhold A.R., Elliott N.C., Newhouse B.N., Tjoa C.M., Sweetnam P.M., Cole M.J., Arriola M.W., Gauthier J.W., Crawford D.T., Nickerson D.F., Pirie C.M., Qi H., Simmons H.A., Tkalcevic G.T. J. Med. Chem. 41:1998;2928.
27. (a) Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. Cell. 95:1998;927
28. (b) Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engström O., Öhman L., Greene G.L., Gustafsson J.-Å, Carlquist M. Nature. 389:1997;753.
29. Elisabetta A., Paolo V., Gabriele A., Paolo C., Massimo G., Maurizio C., Maurizio D., Elisabetta G., Vittorino S. WO98-29403, Chem. Abstr, 1998. 129:2001;95354.
30. (a) Ollis, W. D. In: The Chemistry of Flavonoid Compounds. Geissman, T. A., Ed., Pergamon: Oxford, 1962, pp 353-405.
31. (b)Hepworth, J. D. In: Comprehensive Heterocyclic Chemistry. Katritzky, A. R., Rees, C. W., Eds. Pergamon: New York, 1984, Vol. 3, pp 816-830.
32. Kim D.-K., Kim Y.-W., Gam J., Lim J., Kim K.H. Tetrahedron Lett. 36:1995;6257.
33. Wähälä K., Hase T.A. J. Chem. Soc., Perkin Trans. 1. 1991;3005.
34. Fuji K., Kawabata T., Fujita E. Chem. Pharm. Bull. 28:1980;3662.
35. + 474.1916, found 474.1900.
36. (a) Parker G.J., Law T.L., Lenoch F.J., Bolger R.E. J. Biomol. Screen. 2000;77
37. (b) Mobley, J. A., personal communication.
38. Palkowitz A.D., Glasebrook K., Thrasher J., Hauser K.L., Short L.L., Phillips D.L., Muehl B.S., Sato M., Shetler P.K., Cullinan G.J., Pell T.R., Bryant H.U. J. Med. Chem. 40:1997;1407.
39. (a) Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. J. Med. Chem. 43:2000;4934
40. (b) Stauffer S.R., Huang Y., Coletta C.J., Tedesco R., Katzenellenbogen J.A. Bioorg. Med. Chem. 9:2001;141.